Recursos

Esta seção contém pesquisas internacionais e pode fazer referência a indicações que não são aprovadas em todas as regiões. Consulte as indicações aprovadas localmente antes do uso.

Filtrar por:

Pesquisar
RAMAT GAN, Israel, Nov. 3, 2025 /PRNewswire/ -- Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted
Innovation happens when clinicians and technology come together.
Stop by the GE HealthCare booth to experience Pulsenmore
Pulsenmore (TASE: PULS), a pioneering provider of home-based ultrasound technology, has announced the renewal and expansion of its strategic partnership with Clalit Health Services, Israel's largest HMO. Over the next
Pulsenmore secured a commercial agreement with Sheba Medical Center, Tel Hashomer for remote patient monitoring of highrisk pregnancies using its’ home ultrasound solution. Sheba Medical Center, will utilize Pulsenmore's solution
Pulsenmore (TASE:PULS), the world leader in self-scan ultrasound technology for at-home use and remote clinical diagnosis, announces its new clinical study collaboration with Michigan Medicine. The study will examine the

Notícias da Pulse

Convidamos você a se manter atualizado com as últimas novidades, inscrevendo-se no nosso boletim informativo trimestral

Perguntas Freqentes

Perguntas Freqentes